Synthroid Marketing Litigation

Summary of Case and Settlement:

MDL No. 1182 (N.D. Ill). This multidistrict action arises out of alleged unlawful activities with respect to the marketing of Synthroid, a levothyroxine product used to treat thyroid disorders. On August 4, 2000, the court granted final approval of a settlement in the amount of $87.4 million plus interest. See 188 F.R.D. 295 (N.D. Ill. 1999). On August 31, 2001, approval of the settlement was upheld on appeal. See 264 F.3d 712 (7th Cir. 2001).

Contact Us

First Name

Last Name



Case This Inquiry Relates To